Sphere Fluidics
Sphere Fluidics develops and manufactures single-cell analysis and characterization systems, facilitating advancements in biopharmaceutical discovery and cell therapy. Their Cyto-Mine® technology integrates picodroplet incubation and analysis, streamlining cell line development and monoclonal antibody discovery.News by Sphere Fluidics
Filter by
AllArticlesAudioEbooksEventsInfographicsNewsProductsSurveysDocumentsVideosVirtual EventsWebinars
Enhance lab efficiency and reduce project timelines with Sphere Fluidics’ new Cyto-Mine® Chroma platform
| 1 min read
First in Sphere Fluidics’ new range of 3D cell culture kits in partnership with ClexBio
| 1 min read
Simplified design reduces manufacturing time and offers improved functionality to help streamline antibody discovery, cell line development, cell therapy, and synthetic biology workflows
| 2 min read
Integration of PAA’s S-LAB with Sphere Fluidics’ Cyto-Mine Single Cell Analysis System increases throughput in antibody discovery and cell line development
| 2 min read
Assay-ready reagent kit to reduce timelines and enhance efficiency in cell line development
| 2 min read
Update offers new functionality to enhance workflows in biologics discovery and cell line development
| 2 min read
Sphere Fluidics introduced Cyto-Mine® Studio Software Suite, an updated software for its innovative Cyto-Mine Single Cell Analysis System
| 2 min read
Sphere Fluidics introduced Cyto-Mine® Studio Software Suite, an updated software for its innovative Cyto-Mine Single Cell Analysis System
| 2 min read
A novel and disruptive analysis and monoclonal assurance system for drug discovery and development
| 2 min read
Page 1 of 1 - 9 Total Items
